Biotech firms have developed nearly 40 percent more of key treatments for unmet medical needs, says a new book co-authored by Cambridge researchers. From "Breakthrough to Blockbuster: The Business ...

The next big test is whether using Pluvicto can delay the advancement of prostate cancer enough to delay chemical castration, ...

If he could control these microscopic snips, UC Berkeley historian Sally Smith Hughes writes in her book, Genentech: The Beginnings of Biotech, he could manipulate ... and set the stage for not one ...

Kennedy Jr., invested in gene-editing technology and is owed substantial advances for several books, according to financial ... including stakes in biotech firms CRISPR Therapeutics AG and ...

He currently researches and teaches economic sociology and the social studies of finance at the University of Lucerne in Switzerland.Adam's new book ... Biotechnology is on the front line of ...

"There is something extraordinary in being immersed in a community of biotech medical leaders that dedicate their professional lives to the medicines of tomorrow. The leaders are welcoming ...